MKDTY (Molecular Data) Debt-to-EBITDA : N/A (As of Jun. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Molecular Data Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Molecular Data's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2021 was $13 Mil. Molecular Data's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2021 was $3 Mil. Molecular Data's annualized EBITDA for the quarter that ended in Jun. 2021 was $0 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Molecular Data's Debt-to-EBITDA or its related term are showing as below:

MKDTY's Debt-to-EBITDA is not ranked *
in the Chemicals industry.
Industry Median: 2.11
* Ranked among companies with meaningful Debt-to-EBITDA only.

Molecular Data  (OTCPK:MKDTY) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Molecular Data Debt-to-EBITDA Related Terms

Molecular Data Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Molecular Data's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecular Data Debt-to-EBITDA Chart

Molecular Data Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Debt-to-EBITDA
0.00 -1.55 0.00 -0.09 -0.23

Molecular Data Quarterly Data
Dec17 Dec18 Sep19 Dec19 Jun20 Dec20 Jun21 Sep21
Debt-to-EBITDA Get a 7-Day Free Trial -0.07 N/A N/A N/A N/A

MKDTY vs BLGO, DOW, CE: Debt-to-EBITDA Comparison

For the Chemicals subindustry, Molecular Data's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Molecular Data Debt-to-EBITDA vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Molecular Data's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Molecular Data's Debt-to-EBITDA falls into.


Molecular Data Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Molecular Data's Debt-to-EBITDA for the fiscal year that ended in Dec. 2020 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(7.857 + 3.014) / -47.884
=-0.23

Molecular Data's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(12.815 + 3.068) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2021) EBITDA data.

Molecular Data Business Description

Address 2177 Shenkun Road, 11th Floor, Building 15, Minhang District, Shanghai, CHN, 201106
Molecular Data Inc is a chemical e-commerce platform in China. It provides SaaS-powered and data-driven integrated service platform for chemical e-commerce. The company offers e-commerce solutions, financial solutions, and warehousing and logistics solutions through its platform. The company generates all its revenues through Chemical trading from China. It sells chemical products to customers through an online platform or sales representatives.